bladder cancer phenotype

Aliases

bladder carcinoma

No related entities found.

Mentioned in (47)

Papers in which this entity is mentioned.

• A guide to transcriptomic deconvolution in cancer. (2026)
• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types. (2026)
• Three-dimensional genome landscape of primary human cancers. (2025)
• Transcription start sites experience a high influx of heritable variants fueled by early development. (2025)
• Transient loss of Polycomb components induces an epigenetic cancer fate. (2024)
• Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
• A New Era of Data-Driven Cancer Research and Care: Opportunities and Challenges. (2024)
• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients (2023)
• Predicting tumour content of liquid biopsies from cell-free DNA. (2023)
• Towards understandings of serine/arginine-rich splicing factors. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology. (2021)
• Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing. (2021)
• Evaluating the transcriptional fidelity of cancer models. (2021)
• Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. (2021)
• DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers. (2020)
• Pan-cancer analysis of whole genomes. (2020)
• Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks. (2020)
• Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. (2020)
• The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment. (2019)
• A Compendium of Mutational Signatures of Environmental Agents. (2019)
• Comprehensive analysis of structural variants in breast cancer genomes using single molecule sequencing (2019)
• CNVScope: Visually Exploring Copy Number Aberrations in Cancer Genomes. (2019)
• Pan-cancer whole-genome analyses of metastatic solid tumours. (2019)
• Enter the Matrix: Factorization Uncovers Knowledge from Omics. (2018)
• Enhanced detection of circulating tumor DNA by fragment size analysis. (2018)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
• Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. (2017)
• Universal Patterns of Selection in Cancer and Somatic Tissues. (2017)
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
• A method to reduce ancestry related germline false positives in tumor only somatic variant calling. (2017)
• Comprehensive Analysis of Hypermutation in Human Cancer. (2017)
• Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. (2016)
• Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. (2016)
• APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication. (2016)
• Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
• Systematic pan-cancer analysis of tumour purity. (2015)
• The landscape of long noncoding RNAs in the human transcriptome. (2015)
• Genome-wide analysis of noncoding regulatory mutations in cancer. (2014)
• Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. (2014)
• Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. (2014)
• Mutational heterogeneity in cancer and the search for new cancer-associated genes. (2013)
• An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. (2013)
• Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. (2013)
• Pan-cancer patterns of somatic copy number alteration. (2013)
• Tackling the widespread and critical impact of batch effects in high-throughput data. (2010)
• MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. (2008)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.